Search results for: 'lung in'
- Related search terms
- lung cancer therapeutics market
- Lung Cancer Therapeutics Market Size
- lung trend
- lung cancer therapeutics market size forecast
- lung cancer therapeutics market size forecasts
-
27 Apr 2023  |  Global  |  Technology Research
Technology Innovations and Growth Opportunities in Inhaled Therapeutics
Nanoparticle-based Formulation to Drive Transformational Growth Across Inhaled Vaccines and Monoclonal Antibodies
Inhalation drug delivery involves administering drugs to the lungs through the mouth (pulmonary route) or nose (intranasal route), enabling them to bypass the blood-brain barrier. Small molecules have been the main focus for inhalation delivery, but recent R&D and increased interest in inhalable COVID-19 vaccines have led to a shift toward inhalabl...
$4,950.00
Special Price $3,712.50 save 25 %
-
27 Jul 2021  |  Global  |  Technology Research
Wearable Artificial Organ Growth Opportunities
Technological Innovations Enabling Remote Monitoring and Home Care for Organ Dysfunction
Healthcare providers typically manage kidney failure, diabetes, and respiratory failure with large, bulky medical equipment in a hospital setting. Conventional interventions typically reduce patient mobility; the treatment burden, mental anxiety, potential for non-compliance, and other drawbacks for specific therapies can result in poor health outc...
$4,950.00
Special Price $3,712.50 save 25 %
-
28 Jun 2024  |  Global  |  Technology Research
Innovations and Growth Opportunities in Wearables, Bionics, and Artificial Intelligence (AI)-based Solutions
Advanced MedTech Technology Opportunity Engine (TOE)
The latest issue of Advanced MedTech Technology Opportunity Engine (TOE) profiles a wide range of innovations from the advanced medical devices, medical imaging, digital health, and diagnostics industry. The issue includes advanced medical devices such as implantable wireless sensor, drug-device combination therapy, bionic hands, sutureless device,...
$950.00
Special Price $712.50 save 25 %